发布求助
文献互助 智能选刊 最新文献

Hospital formulary最新文献

筛选
英文 中文
Drug management, cost issues, educational strategies, changing marketplace top agenda. 药品管理，成本问题，教育策略，不断变化的市场。
Hospital formulary Pub Date : 1994-08-01
{"title":"Drug management, cost issues, educational strategies, changing marketplace top agenda.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 8","pages":"552-6"},"PeriodicalIF":0.0,"publicationDate":"1994-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21055666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How a collaborative task force can assist in managing biotechnology products. 协作工作队如何协助管理生物技术产品。
Hospital formulary Pub Date : 1994-07-01
G E MacKinnon
{"title":"How a collaborative task force can assist in managing biotechnology products.","authors":"G E MacKinnon","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The rapid expansion of biotechnology-derived pharmaceuticals into the health care system presents new challenges and concerns in formulary selection, development of usage guidelines, and budgeting. A DUE/QA pharmacy network and a hospital association in a metropolitan area formed a Biotechnology Task Force, whose goals included: developing a forum for practitioners and administrators to exchange information; applying a strategy for evaluating and predicting usage patterns; promoting educational endeavors; and developing database technology to assist institutions with usage monitoring. The task force successfully educated health care professionals and administrators about the ramifications of biopharmaceuticals. Having this process defined will prove beneficial for future evaluation of other biopharmaceuticals.</p>","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 7","pages":"526-30, 533"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21005970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug sampling: legislation proposed; industry receptive to ending practice. 药物抽样:建议立法;行业接受结束实践。
Hospital formulary Pub Date : 1994-06-01
B Gatty
{"title":"Drug sampling: legislation proposed; industry receptive to ending practice.","authors":"B Gatty","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 6","pages":"478, 477"},"PeriodicalIF":0.0,"publicationDate":"1994-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21005755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concurrent ceftazidime DUE with clinical pharmacy intervention. 头孢他啶与临床药学干预同时进行。
Hospital formulary Pub Date : 1994-05-01
A U Okpara, O M Van Duyn, T R Cate, L K Cheung, M A Galley
{"title":"Concurrent ceftazidime DUE with clinical pharmacy intervention.","authors":"A U Okpara,&nbsp;O M Van Duyn,&nbsp;T R Cate,&nbsp;L K Cheung,&nbsp;M A Galley","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Ceftazidime use at our institution, a 580-bed county teaching hospital, has steadily increased since its addition to the formulary in 1986. In response to this increased use and because the institutional antibiogram showed increased resistance by Pseudomonas aeruginosa (from 10 to 28% resistant), the P & T Committee requested that a drug use evaluation (DUE) of ceftazidime be conducted. Analysis of this retrospective pilot study showed that 87% of ceftazidime use was inappropriate. To further evaluate ceftazidime use, to identify problems not assessed during retrospective review, and to correct problems while patients were receiving the drug, a concurrent ceftazidime use evaluation was conducted. The methods and results of the concurrent review are presented below.</p>","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 5","pages":"392-4, 399, 402-4"},"PeriodicalIF":0.0,"publicationDate":"1994-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21006833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals. 40家医院静脉注射h2受体拮抗剂的药物经济学分析。
Hospital formulary Pub Date : 1994-05-01
R Segal, T Oh, R Ben-Joseph, W L Russell
{"title":"A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals.","authors":"R Segal,&nbsp;T Oh,&nbsp;R Ben-Joseph,&nbsp;W L Russell","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The objectives of this study were to determine (1) the expenditures of hospitals for IV histamine2-receptor antagonists (H2-RA), and (2) the cost savings that might be realized if only a single IV H2-RA was purchased for use. Forty hospitals provided data about purchase prices for each IV H2-RA dosage form purchased (cimetidine, ranitidine, and famotidine), the number of each dosage form used during the 12-month study period, purchase price and extent of usage for supplies, labor costs for preparing and administering IV H2-RAs, and IV H2-RA dosage schedules. The study showed that most hospitals were spending more money for IV H2-RAs than necessary given the pricing structures of the three products available to them at the time of this study. Also, that significant cost savings could be realized if a single H2-RA was used exclusively.</p>","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 5","pages":"379-82, 388-91"},"PeriodicalIF":0.0,"publicationDate":"1994-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21008034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Industry must communicate value and contribution of drugs to Congress and public. 工业界必须向国会和公众传达药品的价值和贡献。
Hospital formulary Pub Date : 1994-05-01
B Gatty
{"title":"Industry must communicate value and contribution of drugs to Congress and public.","authors":"B Gatty","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 5","pages":"406, 405"},"PeriodicalIF":0.0,"publicationDate":"1994-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21006834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient controlled analgesia: evaluation of pain management and patient outcome. 患者自控镇痛:疼痛管理和患者预后的评估。
Hospital formulary Pub Date : 1994-04-01
B J Balog, C R Humphrey
{"title":"Patient controlled analgesia: evaluation of pain management and patient outcome.","authors":"B J Balog,&nbsp;C R Humphrey","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>A study was conducted to evaluate patient response to patient controlled analgesia (PCA) devices. All patients were interviewed for this concurrent study. A survey was also taken with the nursing staff for their assessments regarding PCA therapy and comparison of outcomes between morphine and meperidine use. Our goal was to see what improvements could be made in pain management and patient therapy wherever possible.</p>","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 4","pages":"299-300, 303-4"},"PeriodicalIF":0.0,"publicationDate":"1994-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21005116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-effectiveness study of nitrate therapy using a decision analysis methodology. 用决策分析方法研究硝酸盐治疗的成本效益。
Hospital formulary Pub Date : 1994-04-01
E P Larrat
{"title":"Cost-effectiveness study of nitrate therapy using a decision analysis methodology.","authors":"E P Larrat","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The cost-assessment technology of decision analysis was applied to isosorbide dinitrate (ISDN), the standard therapy for angina; isosorbide mononitrate (ISMO), approved mid-1992; and nitroglycerin patches to measure the effect of economics on clinical practice and administrative choices. The evaluation was conducted to illustrate the utility of this method for decision makers in various sectors of the health care system, including physicians, pharmacy benefit administrators, formulary committees, and manufacturers. Findings indicate that despite a higher unit cost for ISMO, total anticipated treatment costs with this new long-acting nitrate are lower than those associated with ISDN (28%) and nitroglycerin patch (16%) therapy in patients with stable angina, and ISMO requires less dosing titration and is associated with fewer tolerance effects.</p>","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 4","pages":"277-8, 280, 283-4 passim"},"PeriodicalIF":0.0,"publicationDate":"1994-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21005115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing the role of physicians in the cost-effective use of pharmaceuticals. 加强医生在具有成本效益地使用药品方面的作用。
Hospital formulary Pub Date : 1994-04-01
D J Shulkin
{"title":"Enhancing the role of physicians in the cost-effective use of pharmaceuticals.","authors":"D J Shulkin","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The appropriate use of pharmaceuticals, like much else in medicine, is receiving increased public scrutiny. Health care practitioners are looking for ways to reduce costs without negatively influencing quality of care. This article reviews methods for physicians and pharmacists to work together to implement cost-effective prescribing practices and assess clinical outcomes. These methods include educational initiatives, administrative programs to restrict ordering practices, use of formularies and prescribing guidelines, financial incentives, and programs that support physician and pharmacist collaboration.</p>","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 4","pages":"262-6, 273"},"PeriodicalIF":0.0,"publicationDate":"1994-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21005114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What strategies can be tried to keep costs of antibiotics and other high-priced drugs from becoming true budget busters? 我们可以尝试什么策略来防止抗生素和其他高价药物的成本成为真正的预算杀手?
Hospital formulary Pub Date : 1994-04-01
J P Jaramilla, J Colombo, L Simon
{"title":"What strategies can be tried to keep costs of antibiotics and other high-priced drugs from becoming true budget busters?","authors":"J P Jaramilla,&nbsp;J Colombo,&nbsp;L Simon","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76912,"journal":{"name":"Hospital formulary","volume":"29 4","pages":"305-8"},"PeriodicalIF":0.0,"publicationDate":"1994-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"21005117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信